DOI QR코드

DOI QR Code

Clinical insights into duodenal-type follicular lymphoma: case series study

  • A Reum Choe (Department of Internal Medicine, Ewha Womans University College of Medicine) ;
  • Ye Ji Jun (Department of Internal Medicine, Ewha Womans University College of Medicine) ;
  • Min-Sun Cho (Department of Pathology, Ewha Womans University College of Medicine) ;
  • Chung Hyun Tae (Department of Internal Medicine, Ewha Womans University College of Medicine) ;
  • Sung-Ae Jung (Department of Internal Medicine, Ewha Womans University College of Medicine) ;
  • Ki-Nam Shim (Department of Internal Medicine, Ewha Womans University College of Medicine)
  • Received : 2025.03.11
  • Accepted : 2025.05.09
  • Published : 2025.07.30

Abstract

In Asia, widespread early detection through endoscopic screening has resulted in higher diagnosis rates of asymptomatic duodenal-type follicular lymphoma (DFL). However, no standardized guidelines exist for diagnosing and managing DFL, and ongoing debates persist regarding the optimal treatment strategies. This retrospective observational study was conducted between February 2018 and July 2024. Endoscopic examination revealed small whitish nodular lesions in the second portion of the duodenum. Seven patients (58.0%) underwent involved-site radiation therapy. Two patients (17.0%) with stage IV disease underwent chemotherapy with rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisolone. Another two (17.0%) received chemotherapy with rituximab combined with cyclophosphamide, vincristine, and prednisone. One patient (8.0%) was treated with rituximab monotherapy. During a median follow-up of 30.2 months, no cases of disease progression were observed. Although radiation and chemotherapy are effective treatments, the slow progression of the disease may make a watch-and-wait strategy appropriate.

Keywords

Acknowledgement

The authors thank Dr. Wonguen Jung, Department of Radiation Oncolocy, Ewha Womans University College of Medicine, for her valuable contributions and expertise in this study.

References

  1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375–2390. https://doi.org/10.1182/blood-2016-01-643569
  2. Duffles Amarante G, Collins G, et al. What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options. Br J Haematol 2020;188:831–837. https://doi.org/10.1111/bjh.16348
  3. Oh CH, Kim HS, DO SI, et al. Gastrointestinal follicular lymphoma: a single-institutional experience of 22 cases with emphasis on the comprehensive clinicopathological analysis and diagnostic re-classification. Anticancer Res 2023;43:4089–4096. https://doi.org/10.21873/anticanres.16598
  4. Kurz KS, Kalmbach S, Ott M, et al. Follicular lymphoma in the 5th edition of the WHO-classification of haematolym neo-plasms-updated classification and new biological data. Cancers (Basel) 2023;15:785. https://doi.org/10.3390/cancers15030785
  5. Yoshino T, Takata K, Tanaka T, et al. Recent progress in follicular lymphoma in Japan and characteristics of the duodenal type. Pathol Int 2018;68:665–676. https://doi.org/10.1111/pin.12733
  6. Takata K, Tanino M, Ennishi D, et al. Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis. Cancer Sci 2014;105:608–615. https://doi.org/10.1111/cas.12392
  7. Alnughmush A, Fakih RE, Alyamany R, et al. Duodenal-type follicular lymphoma: comprehensive insights into disease characteristics and established treatment strategies. Curr Opin Oncol 2024;36:577–582. https://doi.org/10.1097/CCO.0000000000001093
  8. Dada R. Diagnosis and management of follicular lymphoma: a comprehensive review. Eur J Haematol 2019;103:152–163. https://doi.org/10.1111/ejh.13271
  9. Marks E, Shi Y. Duodenal-type follicular lymphoma: a clinicopathologic review. Arch Pathol Lab Med 2018;142:542–547. https://doi.org/10.5858/arpa.2016-0519-RS
  10. Carreras J. The pathobiology of follicular lymphoma. J Clin Exp Hematop 2023;63:152–163. https://doi.org/10.3960/jslrt.23014
  11. Nicolae A, Sabattini E, Ponzoni M, et al. Lymphadenitis/reactive-hyperplasia, mimickers of lymphomas, low-grade B-cell lymphomas, and Hodgkin lymphoma. Hemato 2024;5:350–379. https://doi.org/10.3390/hemato5030026
  12. Je Y, Youn YH. Non-ampullary duodenal tumors. Korean J Helicobacter Up Gastrointest Res 2022;22:265–272. https://doi.org/10.7704/kjhugr.2022.0049
  13. Kang D, Min GJ, Kim TY, et al. The role of small bowel capsule endoscopy in determining the treatment strategy for duodenal follicular lymphoma: a single-center retrospective study. Diagnostics (Basel) 2025;15:193. https://doi.org/10.3390/diagnostics15020193
  14. Tari A, Kitadai Y, Mouri R, et al. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. J Gastroenterol Hepatol 2018;33:1461–1468. https://doi.org/10.1111/jgh.14100
  15. Iwamuro M, Tanaka T, Ennishi D, et al. Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy. Sci Rep 2023;13:5858. https://doi.org/10.1038/s41598-023-32736-9
  16. Lee H, Oh D, Yang K, et al. Radiation therapy outcome and clinical features of duodenal-type follicular lymphoma. Cancer Res Treat 2019;51:547–555. https://doi.org/10.4143/crt.2018.190
  17. Takata K, Okada H, Ohmiya N, et al. Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan. Cancer Sci 2011;102:1532–1536. https://doi.org/10.1111/j.1349-7006.2011.01980.x
  18. Wirth A, Mikhaeel NG, Aleman BM, et al. Involved site radiation therapy in adult lymphomas: an overview of international lymphoma radiation oncology group guidelines. Int J Radiat Oncol Biol Phys 2020;107:909–933. https://doi.org/10.1016/j.ijrobp.2020.03.019
  19. Miyata-Takata T, Takata K, Sato Y, et al. A case of diffuse large B-cell lymphoma transformed from primary duodenal follicular lymphoma. Pathol Int 2014;64:527–532. https://doi.org/10.1111/pin.12197
  20. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: follicular lymphoma (ver. 3. 2024),NCCN; 2024